ライフサイエンスコーパス: nephrectomy

1 ars (before nephrectomy, 1 and 2 years after nephrectomy).

2 erval [95% CI], 0.26 to 0.43, versus radical nephrectomy).

3 hemia reperfusion, followed by contralateral nephrectomy.

4 A total of 123 patients (23%) had delayed nephrectomy.

5 d tubulointerstitial fibrosis after subtotal nephrectomy.

6 renal cell carcinoma who had also undergone nephrectomy.

7 renal failure, adenine diet induced and 5/6 nephrectomy.

8 eral complications solely after living donor nephrectomy.

9 including aorta and lung, after 5/6 subtotal nephrectomy.

10 ining nontransplanted kidney of donors after nephrectomy.

11 collagen in aorta of mice after 5/6 subtotal nephrectomy.

12 renal function outcomes compared to radical nephrectomy.

13 oach in selected patients undergoing partial nephrectomy.

14 in nephrovascular toxins, IS and PCS, after nephrectomy.

15 fects of prolonged clamp time during partial nephrectomy.

16 ion through donor assessment to actual donor nephrectomy.

17 e laparoscopic approach for left-sided donor nephrectomy.

18 ltimate postoperative function after partial nephrectomy.

19 , with similar oncologic outcomes to radical nephrectomy.

20 ctional outcomes after ischemia-free partial nephrectomy.

21 traditional multiple-port laparoscopic donor nephrectomy.

22 LKT) after retroperitoneoscopic living-donor nephrectomy.

23 ant percentage of patients following partial nephrectomy.

24 n) followed by reperfusion and contralateral nephrectomy.

25 p ischemia in 40 patients undergoing partial nephrectomy.

26 t have an increased risk of recurrence after nephrectomy.

27 minimize renal functional loss after partial nephrectomy.

28 main reason for still performing open donor nephrectomy.

29 tment of suspicious renal masses was radical nephrectomy.

30 ize) per tuft in relation to weight gain and nephrectomy.

31 64 patients), and all had undergone previous nephrectomy.

32 pression has been stopped after an allograft nephrectomy.

33 alent oncologic outcomes compared to radical nephrectomy.

34 d 5213 patients (73.0%) treated with radical nephrectomy.

35 renal insufficiency associated with radical nephrectomy.

36 d sensitization has been linked to allograft nephrectomy.

37 nger term complications in donors undergoing nephrectomy.

38 of novel surgical techniques for live-donor nephrectomy.

39 hine requirements in laparoscopic live-donor nephrectomy.

40 and 222 patients (4.3%) treated with radical nephrectomy.

41 noma at high risk for tumor recurrence after nephrectomy.

42 ransplantation was performed after recipient nephrectomy.

43 91%]) gained clinical benefit before planned nephrectomy.

44 stic risk, geographical region, and previous nephrectomy.

45 on to those persons willing to undergo donor nephrectomy.

46 ed informed consent procedure for live donor nephrectomy.

47 -1 in healthy and uremic rats induced by 5/6 nephrectomy.

48 d LOS and decreased narcotic use after donor nephrectomy.

49 d deceased kidney donors and normal poles of nephrectomies.

50 pertrophy was induced by progressive partial nephrectomies.

51 ompared with all previous laparoscopic donor nephrectomies.

52 hort of 100 multiple-port laparoscopic donor nephrectomies.

53 nter experience with 1300 laparoscopic donor nephrectomies.

54 990 and 12/31/2014, we did 2002 living donor nephrectomies.

55 mplications were observed in 14 (22%) of the nephrectomies.

56 and followed up annually for 2 years (before nephrectomy, 1 and 2 years after nephrectomy).

57 partial nephrectomy (35%), unilateral total nephrectomy (10.5%), unilateral partial nephrectomy (4%)

58 omy; 20802, total nephrectomy; 8060, partial nephrectomy; 134985, hysterectomy; and 27445, oophorecto

59 %) total nephrectomies, 2759 (34.2%) partial nephrectomies, 14 047 (10.4%) hysterectomies, and 1782 (

60 artial nephrectomy (4%), and bilateral total nephrectomies (2.5%).

61 ) radical prostatectomies, 1405 (6.8%) total nephrectomies, 2759 (34.2%) partial nephrectomies, 14 04

62 partial nephrectomy (48%), bilateral partial nephrectomy (35%), unilateral total nephrectomy (10.5%),

63 otal nephrectomy (10.5%), unilateral partial nephrectomy (4%), and bilateral total nephrectomies (2.5

64 total nephrectomy with contralateral partial nephrectomy (48%), bilateral partial nephrectomy (35%),

65 ssable for clinical benefit prior to planned nephrectomy; 80 of 104 (76.9%) were men; median [interqu

66 nderwent radical prostatectomy; 20802, total nephrectomy; 8060, partial nephrectomy; 134985, hysterec

67 Kidney function decreased by 30% after nephrectomy (absolute change estimated glomerular filtra

68 Conclusions and Relevance: Nephrectomy after upfront pazopanib therapy could be per

69 0%, which remained elevated at 2 years after nephrectomy (all P<0.001).

70 y low-risk criteria can be safely managed by nephrectomy alone with resultant reduced exposure to che

71 e 4 and higher) CKD after radical or partial nephrectomy among veterans treated for kidney cancer in

72 de H3K36me3 profiles from four cytoreductive nephrectomies and SETD2 isogenic renal cell carcinoma (R

73 alone), recipients of simultaneous bilateral nephrectomies and transplant (simultaneous), and recipie

74 ents were referred for transplant having had nephrectomies and were ultimately not transplanted.

75 d 1925 patients (27.0%) treated with partial nephrectomy and 5213 patients (73.0%) treated with radic

76 the use of nephron-sparing surgery (partial nephrectomy and ablation) increased (from 21.5% to 49.0%

77 two experimental rat models of CKD (subtotal nephrectomy and adenine diet) which show early insulin r

78 ents with reduced GFR, as some causes (e.g., nephrectomy and aging) appear to be associated with a re

79 disease (ADPKD) often need to undergo native nephrectomy and are candidates for kidney transplantatio

80 Miniature swine underwent bilateral nephrectomy and class I-mismatched renal transplantation

81 tomy only and a control group undergoing 5/6 nephrectomy and complete omentectomy.

82 panib therapy prior to planned cytoreductive nephrectomy and continued pazopanib therapy after surger

83 In 45 rats AKI was induced by right nephrectomy and contralateral clamping of the renal pedi

84 on of collectrin is increased after subtotal nephrectomy and during high-salt feeding, raising the qu

85 c VSMCs increased in mice after 5/6 subtotal nephrectomy and in mice producing human angiopoietin-2.

86 fits of nephron sparing surgery over radical nephrectomy and its oncologic equivalency confirmed, the

87 the current advantages of laparoscopic donor nephrectomy and may continue to decrease disincentives t

88 were randomly assigned, stratified by prior nephrectomy and Memorial Sloan-Kettering Cancer Center p

89 Recipients underwent bilateral nephrectomy and orthotopic renal transplantation (day 0)

90 ully applied to radical nephrectomy, partial nephrectomy and pyeloplasty.

91 Lewis rats underwent bilateral nephrectomy and received an orthotopic Dark Agouti renal

92 ce and highlight emerging issues for partial nephrectomy and renal function.

93 long-term oncological equivalence to radical nephrectomy and renal functional benefit, partial nephre

94 similar observations in rats after subtotal nephrectomy and tested whether pharmacologic inhibition

95 he fecal samples of rats 6 weeks after 5/6th nephrectomy and those of sham-operated rats, still sugge

96 vent leading to late rejection and allograft nephrectomy and was an independent predictor of alloanti

97 for 37 patients (1.9%) treated with partial nephrectomy, and 222 patients (4.3%) treated with radica

98 ell histology, 73% of patients had undergone nephrectomy, and 54% of patients were treatment naive.

99 Male C57BL/6 mice underwent 5/6 nephrectomy, and 8 weeks later, they were subjected to L

100 2 nonsmokers who underwent a renal biopsy or nephrectomy, and in CS-exposed mice, we assessed patholo

101 he cohort that did and did not undergo donor nephrectomy, and performed simple linear logistic regres

102 ors that affect renal function after partial nephrectomy, and presents current information about the

103 ay 15 and at months 1, 3, 6, and 9 after the nephrectomy, and then every 3 to 6 months until the last

104 Over 5,000 living kidney donor nephrectomies are performed annually in the US.

105 preliminary results of zero ischemia partial nephrectomy are promising, further research is needed to

106 techniques for minimally invasive live donor nephrectomy are safe and associated with low complicatio

107 onstrate that the majority of T1b/T2 partial nephrectomy are still carried out by open surgery, and c

108 ng born with two kidneys and then undergoing nephrectomy are unclear.

109 ions of renal transplants after living donor nephrectomy are uncommon.

110 physiological changes that occur early after nephrectomy are well documented, less is known about the

111 ses is transforming with adoption of partial nephrectomy as a safe and feasible surgical option with

112 ed laparoscopic and robotic-assisted partial nephrectomy as a safe management option for pathologic T

113 has become the gold standard for live-donor nephrectomy, as it results in a short convalescence time

114 Subsequent rates of documented infection and nephrectomy, as well as patient survival, were ascertain

115 Subsequent rates of documented infection and nephrectomy, as well as patient survival, were ascertain

116 In propensity score-matched cohorts, partial nephrectomy associated with a significantly lower relati

117 of renal transplant alone patients required nephrectomy at 10 years follow-up.

118 ) TSC patient had a left followed by a right nephrectomy at ages 24 and 27.

119 fter hand-assisted laparoscopic living donor nephrectomy at our institution from January 2008 to Febr

120 ell renal cell carcinoma who had undergone a nephrectomy at the Cleveland Clinic (OH, USA).

121 reteral reimplantation, complete and partial nephrectomy, bladder augmentation and creation of contin

122 Timing of bilateral nephrectomy (BN) is controversial in patients with refra

123 ond (male) TSC patient had bilateral partial nephrectomies (both at age 36), with similar findings of

124 ney function, from baseline at 2 years after nephrectomy (both P<0.03).

125 Single-port donor nephrectomy can be integrated as a standardized approach

126 Simultaneous bilateral nephrectomy can be safely performed at the time of renal

127 Partial nephrectomy can now be safely performed without global r

128 Model systems demonstrate that nephrectomy can precipitate hypertrophic podocyte stress

129 murine model in which CKD is induced by 5/6 nephrectomy (CKD mice), we observed defects in glucose-s

130 The role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRC

131 Three hundred eighty-three living donor nephrectomies conducted at one of the United Kingdom's l

132 ereas GFR fell by 70% after IR in unilateral nephrectomy controls.

133 e Wistar rats were subjected to 5/6 subtotal nephrectomy (creatinine clearance, 25% normal).

134 rescence microscopy performed on nondiseased nephrectomy cryosections from persons with normal kidney

135 Use of radical nephrectomy decreased over time (from 69.0% to 42.5%), a

136 and systematic reviews suggest that partial nephrectomy decreases the risks of adverse renal functio

137 e-third of organ-confined cancers treated by nephrectomy develop metastasis during follow-up care.

138 e time between transplantation and allograft nephrectomy did not influence the incidence of DSAs.

139 imally invasive surgical approaches to donor nephrectomy (DN) has been driven by the potential advant

140 Many strategies regarding timing of native nephrectomies exist for patients with symptomatic polycy

141 Post-donor nephrectomy follow-up consisted of standard questionnair

142 Male mice underwent a unilateral (right) nephrectomy followed by 30 minutes of contralateral (lef

143 blished series of minimally invasive partial nephrectomies for such renal masses.

144 s a paucity of data for laparoscopic partial nephrectomies for this larger tumor size.

145 non-DSA anti-HLA antibodies after allograft nephrectomy for early graft loss and to seek the predict

146 lt patients had undergone partial or radical nephrectomy for histologically confirmed ccRCC and fell

147 Partial nephrectomy for larger kidney tumors (T1b) has gained wi

148 here is an increased push to perform partial nephrectomy for larger tumors.

149 Complex partial nephrectomy for multiple renal tumors, or multiplex part

150 asibility of performing laparoscopic partial nephrectomy for renal tumors 4-7 cm in size has clearly

151 ith clinical guidelines recommending partial nephrectomy for small renal masses, it is essential to u

152 Radical nephrectomy for SRMs should only be reserved for patient

153 To review current status of partial nephrectomy for treatment of T1b and T2 renal mass, focu

154 recent clinical trial of partial and radical nephrectomy found minimal differences in survival or adv

155 tween 2000 and December 2013, 106 live donor nephrectomies from anonymous living-donors were performe

156 idney cancer treated with partial or radical nephrectomy from 1992 through 2007.

157 over ischemia time in impacting post-partial nephrectomy function.

158 The first case underwent a radical nephrectomy given the central location of the tumor and

159 Finally, patients treated with a partial nephrectomy had reduced risk of mortality (hazard ratio,

160 Hand-assisted retroperitoneoscopic donor nephrectomy (HARP) is an alternative approach, combining

161 of hand-assisted retroperitoneoscopic donor nephrectomy (HARP).

162 Minimally invasive live donor nephrectomy has become a fully implemented and accepted

163 o-ischemia, approach to laparoscopic partial nephrectomy has been a proposed means of preserving glob

164 arge breadth of data have shown that partial nephrectomy has equivalent oncologic outcomes compared t

165 -clamp technique during laparoscopic partial nephrectomy has variably shown increased intraoperative

166 Laparoscopic and robotic-assisted partial nephrectomy have been widely adopted for the management

167 r survival for patients treated with radical nephrectomy, have generated new uncertainty regarding th

168 Submitted delayed nephrectomy histology showed anaplasia (n = 8; excluded

169 aparoscopic surgery reduces pain after donor nephrectomy; however, most patients still require a sign

170 al prostatectomy, total nephrectomy, partial nephrectomy, hysterectomy, or oophorectomy at 1370 hospi

171 ly, and most would be motivated toward donor nephrectomy if offered a payment of $50000.

172 of the Hem-o-lok clip for laparoscopic donor nephrectomies in 2006, two live kidney donors in the Uni

173 (managed with repeat NSS in 6 and completion nephrectomy in 1) and 3 had an episode of intestinal obs

174 We changed our approach to single-port donor nephrectomy in 2009 and have compared outcomes with trad

175 Uremia was induced by 5/6 nephrectomy in adult female mice.

176 of robotic-assisted surgery only for partial nephrectomy in facilities with medium-high (1.67 [1.13-2

177 The rate of nephrectomy in follow-up was lower in donors versus nond

178 CRD was induced by 5/6 nephrectomy in high-fat high-cholesterol fed apolipoprot

179 nal function were examined in a model of 5/6 nephrectomy in Lewis rats.

180 The likelihood of tumour recurrence after nephrectomy in localised clear cell renal cell carcinoma

181 h established kidney damage, the effect of a nephrectomy in non-chronic kidney disease patients is no

182 The role of partial nephrectomy in nonelective treatment of T2 tumors is mor

183 tion in general and minimally invasive donor nephrectomy in particular are more commonly applied in N

184 e of nephron-sparing surgery exceeds radical nephrectomy in patients who receive surgery.

185 titutional series indicate that open partial nephrectomy in patients with a solitary kidney can achie

186 Importance: The role of cytoreductive nephrectomy in patients with metastatic renal cancer in

187 rmine the long-term risk of partial or total nephrectomy in previous living kidney donors compared to

188 ont pazopanib therapy prior to cytoreductive nephrectomy in previously untreated patients with metast

189 ential to understand the benefits of partial nephrectomy in regards to renal function.

190 renal functional benefit compared to radical nephrectomy in select patients.

191 In our unit's experience, nephrectomy in selected donors who may otherwise have be

192 is becoming an alternate standard to radical nephrectomy in the management of T1b tumors.

193 To determine if observation alone after nephrectomy in very low-risk Wilms tumor (defined as sta

194 , 0.15; 95% CI, 0.11 to 0.19, versus radical nephrectomy) in propensity score-matched cohorts.

195 ecent studies suggest that GFR loss at donor nephrectomy increases the risk of eventual end-stage ren

196 Informed consent in live donor nephrectomy is a topic of great interest.

197 Laparoscopic and robotic-assisted partial nephrectomy is a well tolerated and viable option for pe

198 Adaptive hyperfiltration after donor nephrectomy is attributable to hyperperfusion and hypert

199 ectomy and renal functional benefit, partial nephrectomy is becoming an alternate standard to radical

200 LKT after living-donor nephrectomy is feasible, but it has steep learning curve

201 te superior functional outcomes when partial nephrectomy is performed without global ischemia, even a

202 Although partial nephrectomy is the preferred treatment for many patients

203 we show that kidney transplantation "reverse nephrectomy" is also associated with podocyte hypertroph

204 jury, many studies have suggested that donor nephrectomy itself does not cause long-term loss of GFR

205 Post-partial nephrectomy kidney quantity and quality are surgically n

206 Compared with mini-incision open donor nephrectomy, laparoscopic donor nephrectomy (LDN) is con

207 Laparoscopic donor nephrectomy (LDN) has become the gold standard for live-

208 n open donor nephrectomy, laparoscopic donor nephrectomy (LDN) is considered cost-effective.

209 Subtotal nephrectomy led to insulin resistance and dyslipidemia i

210 rare complication of laparoscopic live donor nephrectomy (LLDN).

211 1Nx-0) after partial (LR-partial) or radical nephrectomy (LR-radical) or as moderate/high risk (M/HR;

212 The five donor nephrectomies made nine kidney transplantations possible

213 atic RCC, with a clear cell component, prior nephrectomy, measurable disease, and 0 or 1 prior therap

214 In the 5/6 nephrectomy model, 20-mg/kg 4SC-101 reduced proteinuria,

215 or higher after radical (n=9759) or partial nephrectomy (n=4370) was 7.9% overall.

216 Furthermore, in those who had nephrectomy of the first allograft, class 2 repeated mis

217 Partial nephrectomy of the left kidney was performed.

218 rimental transplantation model used included nephrectomy of the remaining native kidney at d 5 post-t

219 or in our cohort received a partial or total nephrectomy of their remaining kidney during our follow-

220 e short- and long-term effects of unilateral nephrectomy on living donors have been important conside

221 to estimate the treatment effect of partial nephrectomy on long-term survival.

222 f rats: an experimental group undergoing 5/6 nephrectomy only and a control group undergoing 5/6 neph

223 59 centers (61%) performed endoscopic donor nephrectomy only.

224 Notably, children who undergo nephrectomy or adults who serve as kidney donors exhibit

225 In mice subjected to 5/6 subtotal nephrectomy or unilateral ureteral obstruction, plasma l

226 ery has been successfully applied to radical nephrectomy, partial nephrectomy and pyeloplasty.

227 In conclusion, compared with radical nephrectomy, partial nephrectomy was associated with a m

228 s who underwent radical prostatectomy, total nephrectomy, partial nephrectomy, hysterectomy, or oopho

229 wards improved kidney function after partial nephrectomy, particularly for larger tumors.

230 After nephrectomy, patients were followed without adjuvant che

231 verview of outcomes for laparoscopic partial nephrectomies performed with or without hilar clamping f

232 l ischemia-reperfusion injury and unilateral nephrectomy plus contralateral ischemia-reperfusion inju

233 Partial nephrectomy (PN) for SRMs is the standard treatment that

234 A shift towards partial nephrectomy (PN) in the management of small renal cell c

235 tal uremic cardiomyopathy induced by partial nephrectomy (PNx).

236 and recipients with pretransplant bilateral nephrectomies (pre).

237 tors such as blood transfusion and allograft nephrectomy, prolonged immunosuppression withdrawal rema

238 FGFR4 attenuates established LVH in the 5/6 nephrectomy rat model of CKD.

239 Uni-nephrectomy reduced the body weight at which proteinuria

240 One possibility is that ESRD is due to the nephrectomy-related reduction in GFR, followed by an age

241 eir evolution and promising results, partial nephrectomy remains the cornerstone of surgical treatmen

242 ell carcinoma (RCC) after radical or partial nephrectomy remains unknown, and evidence to support cur

243 multiple renal tumors, or multiplex partial nephrectomy, requires not only exceptional surgical skil

244 ) patients died following partial or radical nephrectomy, respectively.

245 Compared with sham operation, nephrectomy resulted in significant increases in urea an

246 In a screen of nephrectomy samples from 56 patients with RCC, we found

247 WT nephrectomy samples from 586 SIOP WT 2001 patients were

248 hors recommend simultaneous bilateral native nephrectomy (SBN) as the preferred option in living-dono

249 2 at cancer treatment centers with access to nephrectomy services.

250 with such masses minimally invasive partial nephrectomy should be considered for elective and absolu

251 Partial nephrectomy should remain the standard of care for small

252 pression after transplant failure, and graft nephrectomy, showed that AMS (odds ratio [OR]: 1.44 per

253 Unilateral nephrectomy significantly decreased glomerular filtratio

254 Compared with multiple-port donor nephrectomy, single-port patients had similar operative

255 e by renal ischemia-reperfusion or bilateral nephrectomy, small intestinal Paneth cells increased the

256 ransglutaminase isozymes in the rat subtotal nephrectomy (SNx) model of progressive renal scarring.

257 Adriamycin nephrotoxicity and subtotal nephrectomy (SNx) studies indicated that deletion of the

258 K181-V182 and mAbprostasin) to examine human nephrectomy specimens.

259 ibility of the kidney after subtotal (5/6th) nephrectomy (STN) to ischemic injury in rats.

260 PURPOSE OF REVIEW: Partial nephrectomy surgery typically requires clamping the main

261 al anatomy to allow even substantial partial nephrectomy surgery without clamping the main renal arte

262 opens the door to more sophisticated partial nephrectomy surgery, wherein we can now tailor the techn

263 ical refinements, such as anatomical partial nephrectomy surgery.

264 tery appears unnecessary during most partial nephrectomy surgery.

265 comes of unclamped and zero-ischemia partial nephrectomy techniques.

266 noma at high risk for tumor recurrence after nephrectomy, the median duration of disease-free surviva

267 ns of arterial control in laparoscopic donor nephrectomy; thus, a practice with documented fatal outc

268 r, studies comparing enucleation and partial nephrectomy to date have revealed equivalent oncologic o

269 ndard treatment of SRMs evolved from radical nephrectomy to nephron-sparing approaches.

270 veness of partial nephrectomy versus radical nephrectomy to preserve kidney function has not been wel

271 vity (>/= 1+ by immunohistochemistry) in his nephrectomy tumor specimen.

272 Rats status post 5/6 nephrectomy underwent bone marrow transplant from human

273 We used db/db mice with early unilateral nephrectomy (Unx) as a murine model of progressive DN an

274 In rats subjected to unilateral nephrectomy (UNx), we examined cardiac electrophysiologi

275 diate renal hypertrophy following unilateral nephrectomy (UNX).

276 reduction, mice were subjected to unilateral nephrectomy (UNx).

277 80 renal transplantations after living donor nephrectomy, ureteral complications occurred in 18 (3.7%

278 The comparative effectiveness of partial nephrectomy versus radical nephrectomy to preserve kidne

279 on (eGFR>/=60 ml/min per 1.73 m(2)), partial nephrectomy was also associated with a significantly low

280 , compared with radical nephrectomy, partial nephrectomy was associated with a marked reduction in th

281 , treatment with partial rather than radical nephrectomy was associated with improved survival.

282 7.6 years, maximum 21.0 years), the rate of nephrectomy was not statistically different in donors ve

283 metric analysis of glomeruli obtained during nephrectomy was performed in 19 subjects.

284 Nephrectomy was performed in 63 (61%) of patients; 14 (2

285 Allograft nephrectomy was performed in 81% of hospitalized patient

286 Allograft nephrectomy was performed in 81% of hospitalized patient

287 ctive antibody significantly increased after nephrectomy was performed.

288 Transplant nephrectomy was required in 41% of patients who weaned i

289 tage I favorable histology Wilms tumors with nephrectomy weight <550g and age at diagnosis <2 years)

290 Rats with subtotal nephrectomies were lethally irradiated and underwent sal

291 All living-donor nephrectomies were performed by retroperitoneoscopic app

292 ications after minimally invasive live donor nephrectomy were included.

293 e-risk Wilms' tumours assessed after delayed nephrectomy were randomly assigned (1:1) by a minimisati

294 ferral centers, donors undergoing left-sided nephrectomy were randomly assigned to HARP or LDN.

295 kidneys or a solitary kidney from unilateral nephrectomy who underwent contrast material-enhanced com

296 living kidney donors frequently ask whether nephrectomy will affect their future pregnancies.

297 compared outcomes from 135 single-port donor nephrectomies with an immediately preceding cohort of 10

298 only 3 patients (7.1%) underwent unilateral nephrectomy with contralateral NSS.

299 rgical approaches included: unilateral total nephrectomy with contralateral partial nephrectomy (48%)

300 Transplant nephrectomy with cystectomy was performed as a secondary

301 ients completed successful single-port donor nephrectomy without major complication or open conversio